Two cases of valproic acid poisoning treated with l-carnitine
Authors:
- 1 December 2007
- journal article
- research article
- Published by SAGE Publications in Human & Experimental Toxicology
- Vol. 26 (12) , 967-969
Abstract
Two cases of acute valproic acid poisoning with central nervous system depression and raised ammonia level without hepatotoxicity were reported. They were treated successfully with the use of the antidotes: l-carnitine and other supportive measures. Clinical manifestation and progress was described, and discussion is focused on the use of l-carnitine in valproic acid–induced hyperammonemia, from its mechanism to the clinical experiences in the literature. Based on the favorable response of our two cases and the literature review, we recommend the administration of intravenous l-carnitine in patients of valproic acid overdose with hyperammonemia or valproic acid–induced hyperammonemic encephalopathy and hepatotoxicity at a dose of 50 mg/kg every 8 h for the first initial 24 h with further individual assessment.Keywords
This publication has 7 references indexed in Scilit:
- 2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance SystemThe American Journal of Emergency Medicine, 2005
- l-carnitine was safely administered in the setting of valproate toxicityThe American Journal of Emergency Medicine, 2005
- Valproate-Induced Hyperammonemic EncephalopathyMetabolic Brain Disease, 2002
- Valproic Acid Toxicity: Overview and ManagementJournal of Toxicology: Clinical Toxicology, 2002
- Hyperammonemia and Coma without Hepatic Dysfunction Induced by Valproate TherapyAcademic Emergency Medicine, 2001
- Effect of l -carnitine treatment for valproate-induced hepatotoxicityNeurology, 2001
- The Role of Carnitine Supplementation during Valproic Acid TherapyAnnals of Pharmacotherapy, 2000